Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Slager

Showing results (191-200 of 277) with videos related to

Pageof 28
Sort By:
Cancer Causes & Control : CCC|June 6, 2019
Blood transfusion history and risk of non-Hodgkin lymphoma: an InterLymph pooled analysisJames R Cerhan, Eleanor Kane, Claire M Vajdic, et al.
Blood Cancer Journal|September 1, 2022
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinibPaul J Hampel, Kari G Rabe, Timothy G Call, et al.
Blood Cancer Journal|February 5, 2025
Genomic characterization of chronic lymphocytic leukemia in patients of African ancestryCecilia Bonolo de Campos, Chantal E McCabe, Laura A Bruins, et al.
Occupational and Environmental Medicine|October 7, 2022
Herbicide use in farming and other jobs in relation to non-Hodgkin's lymphoma (NHL) riskAnneclaire J De Roos, Lin Fritschi, Mary H Ward, et al.
Blood Advances|March 6, 2023
Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLLRosalie Griffin, Julia E Wiedmeier-Nutor, Sameer A Parikh, et al.
American Journal of Hematology|October 26, 2021
Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosisEli Muchtar, Amber B Koehler, Michael J Johnson, et al.
Journal of Thrombosis and Haemostasis : JTH|September 29, 2024
Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolismAmber B Koehler, Kari G Rabe, Daniel J Crusan, et al.
Cytokine|September 7, 2013
Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: results from two independent cohortsHervé Ghesquières, Matthew J Maurer, Olivier Casasnovas, et al.
Blood|December 3, 2014
BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphomaCristina Correia, Paula A Schneider, Haiming Dai, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 12, 2013
Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypesSusan L Slager, Sara J Achenbach, Yan W Asmann, et al.
Pageof 28

Showing results (191-200 of 277) with videos related to

Sort By:
Pageof 28
Cancer Causes & Control : CCC|June 6, 2019
Blood transfusion history and risk of non-Hodgkin lymphoma: an InterLymph pooled analysisJames R Cerhan, Eleanor Kane, Claire M Vajdic, et al.
Blood Cancer Journal|September 1, 2022
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinibPaul J Hampel, Kari G Rabe, Timothy G Call, et al.
Blood Cancer Journal|February 5, 2025
Genomic characterization of chronic lymphocytic leukemia in patients of African ancestryCecilia Bonolo de Campos, Chantal E McCabe, Laura A Bruins, et al.
Occupational and Environmental Medicine|October 7, 2022
Herbicide use in farming and other jobs in relation to non-Hodgkin's lymphoma (NHL) riskAnneclaire J De Roos, Lin Fritschi, Mary H Ward, et al.
Blood Advances|March 6, 2023
Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLLRosalie Griffin, Julia E Wiedmeier-Nutor, Sameer A Parikh, et al.
American Journal of Hematology|October 26, 2021
Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosisEli Muchtar, Amber B Koehler, Michael J Johnson, et al.
Journal of Thrombosis and Haemostasis : JTH|September 29, 2024
Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolismAmber B Koehler, Kari G Rabe, Daniel J Crusan, et al.
Cytokine|September 7, 2013
Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: results from two independent cohortsHervé Ghesquières, Matthew J Maurer, Olivier Casasnovas, et al.
Blood|December 3, 2014
BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphomaCristina Correia, Paula A Schneider, Haiming Dai, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 12, 2013
Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypesSusan L Slager, Sara J Achenbach, Yan W Asmann, et al.
Pageof 28